News

DarioHealth Achieves Over 100 Studies, Enhancing Digital Health Credibility

DarioHealth Achieves Over 100 Studies, Enhancing Digital Health Credibility

DarioHealth Reaches Milestone with 100+ Scientific Publications

A growing collection of peer-reviewed studies underlines DarioHealth’s status as a reliable digital health partner for organizations aiming to reduce costs and enhance outcomes.

DarioHealth Corp. (NASDAQ: DRIO) has reached a significant milestone by surpassing 100 scientific studies, encompassing peer-reviewed journal articles and abstracts from conferences. This achievement reinforces Dario’s commitment to providing validated outcomes for employers and health plans.

With this achievement, Dario stands out among digital health vendors due to the extensive and mature evidence it provides. This evidence is crucial as more self-insured employers and health plans seek proven outcomes rather than vague engagement metrics.

When compared to its industry counterparts, Dario's body of research reflects one of the most developed evidence bases in the digital health sector, stemming from a sizeable number of independent studies initiated by third-party investigators.

What distinguishes Dario's research extends beyond mere quantity. Key attributes include:

  • Involvement of large study populations that mirror actual employer and health plan member bases.
  • Longitudinal study designs, some extending up to two years.
  • Replication of outcomes across multiple studies, validating important metrics.
  • Independent validations conducted by unbiased third-party researchers.
  • Directly observed outcomes like verified claims reductions and actual improvements in HbA1c levels.
  • Evaluations across multiple conditions, which show how various health needs intersect among population groups.

"For employers and health plans, having scientific backing and credible evidence is essential," stated Omar Manejwala, MD, Chief Medical Officer at DarioHealth. "Surpassing the 100-study threshold underscores the reliability and repeatability of Dario's outcomes, all supported by a robust scientific framework."

As the healthcare landscape continues to transition towards value-based care and vendor consolidation, Dario's expanding library of peer-reviewed publications emphasizes the company's position as a reliable partner focused on delivering measurable impacts efficiently.

About DarioHealth Corp. (NASDAQ: DRIO)

DarioHealth Corp. stands at the forefront of digital health innovation, transforming the management of chronic conditions through a user-centric digital therapeutics platform. Dario’s solutions provide tailored and adaptive interventions powered by data analytics and personalized coaching for conditions such as diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

This innovative platform enables individuals to receive ongoing and personalized care, moving away from traditional episodic healthcare approaches. By empowering users to holistically improve their lifestyles for long-term health changes, Dario ensures that adopting good practices becomes easier, resulting in high satisfaction and significant outcomes.

Dario offers its highly-rated services globally, targeting health plans, self-insured employers, care providers, and consumers. To learn more about Dario and its comprehensive digital health solutions, visit dariohealth.com.

Frequently Asked Questions

What recent milestone has DarioHealth achieved?

DarioHealth has achieved over 100 scientific studies, showcasing its commitment to evidence-based digital health solutions.

How does DarioHealth differentiate itself in the digital health market?

DarioHealth stands out due to its extensive network of peer-reviewed research and independent validations that prove the effectiveness of its digital health solutions.

What kind of impact do Dario's solutions aim to deliver?

Dario aims to deliver measurable results in chronic condition management, focusing on improving health outcomes and reducing costs for employers and health plans.

For whom does DarioHealth provide its services?

DarioHealth provides services to health plans, self-insured employers, care providers, and individuals seeking effective health management solutions.

What types of conditions does DarioHealth's platform address?

DarioHealth's platform supports a variety of chronic conditions, including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health issues.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Photronics Faces Legal Heat: Key Investor Steps Now

Updated Category News Views 0

Eyes on Photronics: A Legal Quake Anytime you hear a stock price nosedive like a kamikaze just blew up its own runway, it ought to set off every investor's alarms. And if you’re tied into Photronics (NASDAQ:PLAB), buddy, it's time to catch up on what's driving this train off the rails. With a class period stretching from December 2025 through May 2026, the dish is a...

Continue Reading
Lyntris Advances KSAT Hyperion Satellite Program Milestone

Updated Category News Views 0

Lyntris and KSAT: A Technological Feat in Space Connectivity Well, if it ain't Lyntris back in the headlines again, pushing the envelope on space connectivity. If you're keeping tabs on the space tech space, there's a cracker of a development brewing. Lyntris Inc. (NYSE: LYNX) just checked off a crucial box in their playbook—the Critical Design Review, or CDR for those...

Continue Reading
Jim Morey Joins Pickleman's to Drive Expansion

Updated Category News Views 2

Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 1

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 1

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
FirstEnergy's Bold Move: Dormo Joins to Boost Power

Updated Category News Views 1

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 1

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
McCann Systems Scores Big with Dual AV Awards Wins

Updated Category News Views 0

Piling Up the Accolades: McCann Systems Does It Again You know, getting industry awards can sometimes feel like counting beans, but when a company's snagging them year after year, that’s worth noting. McCann Systems is strutting its stuff with two Commercial Integrator Awards in 2026, cementing their reputation not just here in New Jersey, but across the AV industry....

Continue Reading
Money Market Funds Surge to Record $7.98 Trillion

Updated Category News Views 0

When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...

Continue Reading
Weight Loss Drugs Linked to Genetic Hair Loss in Men

Updated Category News Views 1

When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...

Continue Reading

Top 5 Most Recently Viewed Articles

Moroccan All Shares Experience Decline as Sectors Struggle

Updated Category News Views 64

The Effect of Declining Sectors on Moroccan Stocks Recent trading in Morocco reveals a slight downturn in the stock market, particularly impacting the Moroccan All Shares index, which has dipped by 0.53%. This decline is largely due to losses in several major sectors, notably beverage, real estate, and utilities. As the market evolves, investors are attentively watching...

Continue Reading
Bombardier Launches the Incredible Global 8000 Business Jet

Updated Category News Views 211

Introduction to the Global 8000 Business Jet The Global 8000 is the pinnacle of civil aviation, representing the fastest business jet ever produced. With a breathtaking top speed of Mach 0.95 and an impressive range of 8,000 nautical miles, this aircraft stands out as a revolutionary achievement in the realm of private aviation. It features the industry's lowest cabin...

Continue Reading
Exciting New Stock Option Granted by Taysha Gene Therapies

Updated Category News Views 145

Taysha Gene Therapies Grants Stock Option to New Employee DALLAS — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), an innovative biotechnology company focused on developing groundbreaking gene therapies for serious central nervous system disorders, has recently made news by granting a notable stock option. This strategic decision aims to attract and retain top talent...

Continue Reading
Engine Starter Fluid Market Growth Driven by Demand for Reliability

Updated Category News Views 108

Engine Starter Fluid Market Overview The engine starter fluid market is rapidly evolving, with a notable valuation of USD 362.8 million recorded in a recent report. This market is projected to grow significantly, reaching USD 450 million by the year 2025, representing an annual growth rate of 4.8%. Over the forecasted period from 2025 to 2035, the market is expected to...

Continue Reading
Japan's Approval of KOSTAIVE® Vaccine Marks COVID-19 Milestone

Updated Category News Views 167

Japan’s Health Ministry Approves KOSTAIVE® Vaccine In a significant step for public health, Japan's Ministry of Health, Labor and Welfare has approved the KOSTAIVE® vaccine from CSL and Arcturus Therapeutics. This cutting-edge self-amplifying mRNA COVID-19 vaccine is specifically aimed at battling the JN.1 strain of the Omicron variant. This approval underscores both...

Continue Reading